The Phase 1 Trial Setup Toolbox
Summary: Initiating first-in-human studies after an Investigational New Drug (IND) clearance — how are the experts doing it in 2022? This Endpoints Studio panel of drug developers will discuss innovative trial designs, on-demand manufacturing, communicating between clinical partners, prepping a strong regulatory submission and enabling faster decision making in your phase I trial.